Orum Therapeutics, Inc.

Research Orum Therapeutics, Inc. (475830.KQ) on Bullrun: market cap KRW 364.89B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker475830.KQ
ExchangeKQ
CountrySouth Korea
SectorHealthcare
IndustryBiotechnology
CurrencyKRW
Market capKRW 364.89B
Financial periodQ2 2026
RevenueKRW 24.11M
Net incomeKRW 63.38B
Free cash flow-KRW 19.07B
Gross margin100.0%

Valuation Snapshot

latest market cap is KRW 364.89B.

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	KRW 23.56M	n/a	n/a	100.0%	n/a	KRW 4.07B	KRW 25.50B	KRW 130.89B

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-18	KRW 364.89B	n/a	n/a	n/a

Dividend history

About Orum Therapeutics, Inc.

Orum Therapeutics, Inc., a biopharmaceutical company, engages in the research and development of pharmaceuticals for cancer and immune diseases in South Korea and the United States. The company develops ORM-6151, which is in Phase I clinical trial for the treatment of acute myeloid leukemia and myelodysplastic syndromes; ORM-1153, which is in pre-clinical trial for the treatment of acute myeloid leukemia and hematologic malignancies;

Related stock research

South Korea stocks South Korea Healthcare stocks A-Z stock index

Other Healthcare stocks

ORIENT BIO Inc. (002630.KS) GC Corp. (005250.KS) Pharmicell Co., Ltd. (005690.KS) Kanaph Therapeutics Inc. (0082N0.KQ) Samik Pharmaceutical Company LTD. (014950.KQ) HLB Co., Ltd. (028300) Mgen Solutions Co., Ltd. (032790.KQ) Daesung Microbiological Labs. Co., Ltd. (036480.KQ) Seoulin Bioscience Co.,Ltd. (038070.KQ) Hyundai Bioscience Co., Ltd. (048410.KQ) iNtRON Biotechnology, Inc. (048530.KQ) Synergy Innovation Co., Ltd. (048870.KQ)

Frequently asked questions

What is Orum Therapeutics, Inc.'s market cap?

Orum Therapeutics, Inc.'s market capitalization is KRW 364.89B.